Efficacy and Safety of Palbociclib and Fulvestrant in Japanese Patients With ER+/HER2– Advanced/Metastatic Breast Cancer

Background/Aim: Published data have shown that palbociclib-fulvestrant can significantly improve the progression-free survival (PFS) of estrogen receptor-positive/human epidermal growth factor receptor 2-negative (ER+/HER2–) metastatic breast cancer patients, but not of Japanese patients. We conduct...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:In Vivo
Hoofdauteurs: SEKI, HIROHITO, SAKURAI, TAKASHI, MAEDA, YUKA, OKI, NAOHIKO, AOYAMA, MINA, YAMAGUCHI, RYOU, TOKUDA, TOSHIKI, KABURAGI, TAKUJI, OKUMURA, TAKEHIRO, KARAHASHI, TSUYOSHI, NAKAJIMA, KENICHIRO, HIGETA, KAORI, SHIMIZU, KEN
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: International Institute of Anticancer Research 2019
Onderwerpen:
Research Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6899113/
https://ncbi.nlm.nih.gov/pubmed/31662535
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21873/invivo.11701
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items